Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 3
Page 3 of 70 · 635 articles
Multi-State Licensure After Discipline in One State
A board action in one state can trigger automatic suspension, NPDB reporting, and renewal disclosure duties everywhere else a phys…
Target Letters: Reading Yours Accurately
A DOJ target letter signals substantial evidence, not an indictment. What target status means, the window it opens, and the respon…
Medical Board Investigations: The First Contact
How medical board complaints move from intake to investigator contact, whether interview requests are truly voluntary, and how to…
Treble Damages and Per-Claim Penalties Explained
Treble damages and per-claim penalties can turn a small False Claims Act sample into a seven-figure demand fast for healthcare pro…
Speaker Programs and Kickback Enforcement
OIG's Special Fraud Alert put physician speaker programs under Anti-Kickback Statute scrutiny, and 2025 settlements confirm active…
Remote Therapeutic Monitoring Billing Compliance
CPT 98975 through 98981 cover Remote Therapeutic Monitoring, a distinct billing structure from RPM with its own data, documentatio…
Podiatry Wound Care Audits
Routine foot care exclusions, at-risk exception documentation, and debridement coding standards are driving new Medicare audits of…
Responding to a Wound Care ADR From Your MAC
The 45-day deadline, chart elements MAC reviewers check, and submission mechanics for a wound care Additional Documentation Reques…
Originating Site Rules and Their Audit Consequences
Medicare's telehealth originating site waiver runs through 2027, but audits test each claim against the rule in effect on its date…